Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects
Clinical trial NCT02164812 · COMPLETED
Trial details
- NCT number
- NCT02164812
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-08-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.